Status | Study |
Completed |
Study Name: Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B Condition: Diphtheria Pertussis Tetanus Date: 2011-05-26 Interventions: Biological: Quinvaxem A single dose (0.5 mL) of Quinvaxem |
Completed |
Study Name: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older Condition: Diphtheria Tetanus Poliomyeli Date: 2011-01-31 Interventions: Biological: Diphtheria, tetanus, polio and pertussis vaccination 1 dose of REPEVAX (0.5 mL) at Day 0, 1 |
Completed |
Study Name: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults Condition: Diphtheria Pertussis Tetanus Date: 2010-12-23 Interventions: Biological: GSK Biologicals' combined diphtheria, tetanus, acellular pertuss |
Completed |
Study Name: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine Condition: Diphteria, Tetanus and Pertussis Date: 2010-12-16 Interventions: Biological: GSK Biologicals' reduced-antigen-content diphtheria-tetanus-acel |
Completed |
Study Name: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old Condition: Diphtheria Tetanus Pertussis Date: 2010-11-17 Interventions: Biological: Concomitant administration |
Completed |
Study Name: Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-05-14 Interventions: Biological: Monovalent glyco-conjugated vaccine against Haemophilus influenz |
Completed |
Study Name: An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster Condition: Tetanus Diphtheria Pertussis Date: 2009-03-26 Interventions: Biological: Td5ap Intramuscula |
Completed |
Study Name: Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td Condition: Diphtheria Tetanus Date: 2008-01-15 Interventions: Biological: Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine |
Completed |
Study Name: Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age Condition: Pertussis Diphtheria Date: 2007-09-04 Interventions: Biological: Tetanus and diphtheria toxoids and acellular pertussis 0.5 mL, Intramuscular |
Completed |
Study Name: Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine Condition: Diphtheria Tetanus Pertussis Date: 2007-08-08 Interventions: Drug: Boostrix polio 1 dose (0.5 ml) i.m. |